The path to a successful HIV vaccine depends on a critical first step—activating specific immune cells that induce broadly neutralizing antibodies. Reporting Jan. 4 in the journal Cell, a research ...

The potential utility of neutralizing antibodies as anti-viral treatments have led many researchers to study the humoral immune response to the severe acute respiratory syndrome coronavirus 2 ...

Standing out from the crowd illustration. Businessman thinking twice about following the crowd over a cliff. Files included – jpg, ai (version 8 and CS3), svg, and eps (version 8) While common sense ...

When children living with HIV are injected with neutralizing antibodies, the treatment can suppress cells that contain the virus and are capable of reactivating, an early-stage trial found. Details of ...

Recent progress on monoclonal antibodies raises the possibility that the means to prevent and treat SARS-CoV-2 infections may soon be at hand. The hope arises from discoveries of antibodies that have ...

Researchers have developed a novel neutralizing agent, which becomes stronger as the coronavirus mutates. The emergence of unpredictable variants and their stronger infectivity make the COVID-19 ...

Longevity of neutralizing antibodies is an essential factor for an effective HIV-1 vaccination. An international team has for the first time researched the longevity of neutralizing antibodies in ...

Since it was first identified in 1983, HIV has infected more than 85 million people and caused some 40 million deaths worldwide. While medication known as pre-exposure prophylaxis, or PrEP, can ...

Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533 Vaccine-induced nAbs are detectable at much lower rates ...